Related Experiment Video
Updated: May 27, 2025

08:41
Mouse Round Spermatid Injection
Published on: January 26, 2024
646
SARS-CoV-2 compromises blastocyst quality by modifying the ovarian microenvironment
Chen Geng1,2, Min Zhang1,2, Ning Wang1,2
1The Second Hospital of Shandong University, Institute of Women, Children and Reproductive Health, Shandong University, Jinan, China.
Signal Transduction and Targeted Therapy
|February 18, 2025
Summary
No abstract available in PubMed .
Related Concept Videos
Oogenesis
63.3K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.3K
Teratogenicity
2.3K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.3K
Cleavage and Blastulation
44.6K
After a large-single-celled zygote is produced via fertilization, the process of cleavage occurs while zygotes travel through the uterine tube. Cleavage is a mitotic cell division that does not result in growth. With each round of successive cell division, daughter cells get increasingly smaller.
44.6K

